Skip to main content

Faculty Viewpoints

  • It’s Time to Disentangle from China

    As the risks of dependence on China become more apparent, a few companies are diversifying their supply chains. But inertia and short-term thinking are keeping many companies tethered to markets and suppliers in the world’s second-largest economy, write Yale SOM’s Jeffrey Sonnenfeld and Steven Tian and investor Kyle Bass.

    The Zhongfu Shenying Carbon Fiber Company in Xining, China
  • Could Better Rules Have Saved Silicon Valley Bank?

    Was the closure of Silicon Valley Bank in March a failure of regulation? Greg Feldberg, director of research at the Yale Program on Financial Stability, recently investigated what could have happened if tighter regulations had applied to SVB. He found that better rules could have made a difference.

    A man reads a notice on the door of Silicon Valley Bank while someone talks on a cell phone inside.
  • Virtual Lecture: Silicon Valley Bank and the Anatomy of a Bank Run

    In this extended video, Prof. Andrew Metrick, director of the Yale Program on Financial Stability, explains why Silicon Valley Bank failed earlier this year, and what the collapse tells us about banking, bailouts, and the nature of financial crises.

    A screenshot of Andrew Metrick lecturing with a table of assets and liabilities
  • Why Connecticut’s Investments Are Underperforming

    Yale SOM’s Jeffrey Sonnenfeld and Steven Tian and their team found that Connecticut’s return on its pension fund investments is among the worst in the nation. Their analysis of all 50 states offers some avenues for improvement.

    The Connecticut State Capitol in Hartford with dark clouds in the sky
  • Is It Smart to Be a ‘Stupid Genius’ Like Elon Musk?

    Yale SOM leadership expert Jeffrey Sonnenfeld asks if the CEO’s eccentricities and forgotten promises are undermining his leadership of Twitter, Tesla, and SpaceX.

    Elon Musk carrying a sink through Twitter headquarters
  • Has the CRISPR Revolution Arrived Yet?

    The first drugs using the CRISPR technique are approaching the market, with the potential to transform the lives of people with certain genetic illnesses. We talked with Dr. Greg Licholai about the state of the technology.

    Confocal Fluorescence Microscopy of CRISPR-generated knockout cells. 
  • Cynicism and Ageism Are Drowning Out Biden’s Accomplishments as He Seeks Second Term

    Yale SOM leadership expert Jeffrey Sonnenfeld writes that cynical media coverage and unwarranted concern over Biden’s age have muted the remarkable achievements of his first term.

    President Joe Biden speaking at an event
  • Personal Finance: Popular Authors vs. Economists

    Before teaching a personal finance course, Prof. James Choi dipped into some popular books on the topic. He found that much of what personal finance gurus suggest is at odds with economic research—but that they also have insights into human nature that are sometimes missing from economic analyses.

    An illustration of a woman standing on top of a pile of coins
  • The Dominion Settlement Is Just the Beginning of Fox’s Nightmare

    Yale SOM’s Jeffrey Sonnenfeld and Steven Tian write that the historic settlement and the revelations that preceded it have left Fox Corporation damaged and vulnerable to additional litigation.

    A sign reading "How do you Fox News?"
  • Remembering Oz Nelson, Who Reinvented UPS

    In the 1990s, Nelson modernized the shipping company and gave it a new focus on the customer. Yale SOM’s Jeffrey Sonnenfeld remembers the former CEO, who died on April 6.

    Oz Nelson in his office